Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Where's the quarterly update? This bl''dy company and CEO are a total joke.
Goverment and Valirx
How can so few con so many.
Mainly because we are all stupid enough to believe them. JMO
I was about to post the same. After all these years he is still here with no investment.
No shareholder is going to listen to what you have to say unless you invest first. You have been moving from one thing to another for around 3 years. Very strange indeed to waste time on something he regards as having no value.
Love how you refer to “we” I think you believe you are a shareholder, but you aren’t are you!
What is with the ‘we’? You really are a shifty, unscrupulous 🐖
I would suspect three months notice paid but could be more as she is CEO. As it stands she could hold on a lot longer, let’s face it she is hardly going to rush to find her own replacement
Meanwhile, why in God’s name Adrian withdrew the Requisition notice is beyond me, we could have at least offloaded both Kevin Cox and Martian Lampshire end of this month - as it stands it looks like we are stuck with them both.
Standard notice period salary. P45 in the post
At what cost though? CEO's generally do not go cheaply
Yes, I think RF are looking for new clients after nearly sinking Sareum! Dilly should be a walkover for them!
Yep, she was trying to be clever, blew up in her face and she's been ousted!
Did I miss something? Last I saw the Board change request had rejected as illegal.
Suzy wont sort anything out Porky and as well you know. She was given her marching orders.
So you want 10 evaluations at £100 k a pot then after BOD salary leaves you with zero money to pay for lab staff or to invest in CLX. If there is no lab then you need to pay to outsource the compounds which cost more.
Your finance calculations are as bad as it was when you invested in 4D.
Constantly changing BOD is not going to change the outcomes. The outcomes need to be achieved. Changes only slows things down but then again you are not invested.
Yes and if focus had been on cancer drug dev rather than a Poxy lab start up just to maintain salary and bonus benefits for the board as an ongoing lifestyle business I might agree with you. The handling of 201 a specific example of how bad the management has been.
A p poor director does not wake up the next day and suddenly become a good one. Sorry but until the board changes happen my view remains this is uninvestable. And the longer it takes the worse it will get.
The best out come here is to clear the deck, remove the deadwood have a new board with focus on what matters, reduce cash burn back to under £1.5m and have this in situ ready for H2. At that point the new BOD with that vision could raise and drive it forwards.
If that doesn’t happen and all the current BOD drainers remain this will either close completely as it won’t secure further shareholder capital to continue or Suzy will secure death spiral finance to extend it that bit longer and then it will close completely.
Having no clinical trials doesn't seem to be pulling in the crowds either.
My reason for investing in Valirx is purely because of the low risk strategy. No clinical trials and looking for an early deal that would offer significant upfront payment and milestones.
If the strategy changed in the future I would be out. I don't believe that funding clinical trials on AIM would result in a return in investment in most cases especially in a bearish market.
'Valirx is not at that stage yet and also not full of institutional investors.'
PM clearly looks forward to the day that VAL can be like REDX (and delist from AIM). Maybe he has overlooked that REDX are down 66% today?
Bit stupid to make a like for like comparison. They will probably list on Nasdaq so they have access to greater funds to fund the many 10s of millions they require to fund late stage trials which is very hard to raise on the AIM.
Valirx is not at that stage yet and also not full of institutional investors.
It does mean less competition and hopefully less choice. If outcomes are positive Valirx could move big.
@HD
Utter nonsense - The BOD and ONLY the BOD are culpable for the current state of this penny share due to the past history of dire decisions made. They have run it into the ground.
There is however a chink of light, should the appropriate board changes get sorted ready for H2. Until then the stock remains uninvestable but there is always hope the changes will come in time to avoid a Redx situation.
Just vile, the pair of you. It's clear to everyone else what you 2 are up to, but with a Bio stock trying to help cancer treatments, the morals of the pair of you is second to none. Just Vile.
@HD
Oh grab a sense of humour, have a bit more of your egg.
Geez, you and Slater are out in force on ad vfn Porky. For a couple of chaps not invested/not interested in investing you are both certainly hammering the bbs. Wonder why that may be? pond scum, the pair of you.
@Ratcliffewriter
Loved your Norwegian Blue analogy to 201 - classic, lol.
Owner: Oh yes, the, uh, the Norwegian Blue...What's,uh...What's wrong with it?
Mr. Praline: I'll tell you what's wrong with it, my lad. 'E's dead, that's what's wrong with it!
Owner: No, no, 'e's uh,...he's resting.
Mr. Praline: Look, matey, I know a dead parrot when I see one, and I'm looking at one right now.
Owner: No no he's not dead, he's, he's restin'! Remarkable bird, the Norwegian Blue, idn'it, ay? Beautiful plumage!
Where's the quarterly update Suzy? You may not give 2 sh#tes now you have been shown the door, but you are still CEO for the time being, so do your job. Still totally confident and unconcerned love?
'At the moment nothing really is priced in.'
No - continued failure and dilutatory finance with a supportive shareholder base is priced in. What happens when many people stop believing and buying more shares to average down?